- JP-listed companies
- COSMO BIO COMPANY, LIMITED
COSMO BIO COMPANY, LIMITEDJP:3386
Market cap
¥5.9B
P/E ratio
14.1x
Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | |
Net sales | 7,241 | 7,050 | 7,235 | 7,357 | 7,427 | 7,068 | 7,261 | 7,590 | 8,092 | 9,231 | 9,553 | 9,340 |
Cost of sales | 4,057 | 4,429 | 4,811 | 4,976 | 4,655 | 4,535 | 4,602 | 4,710 | 4,940 | 5,572 | 6,112 | 6,090 |
Gross profit (loss) | 3,184 | 2,620 | 2,424 | 2,380 | 2,772 | 2,532 | 2,659 | 2,879 | 3,152 | 3,658 | 3,440 | 3,249 |
Selling, general and administrative expenses | 2,386 | 2,349 | 2,261 | 2,180 | 2,257 | 2,339 | 2,330 | 2,474 | 2,399 | 2,609 | 2,624 | 2,729 |
Operating profit (loss) | 798 | 271 | 162 | 200 | 514 | 193 | 328 | 405 | 752 | 1,048 | 816 | 519 |
Interest income | - | - | 1 | - | - | - | - | - | - | - | - | - |
Interest on securities | 12 | 9 | 6 | 4 | 3 | 2 | 2 | 2 | 2 | 3 | 3 | 6 |
Dividend income | - | - | - | 15 | 15 | 21 | 24 | 29 | 34 | 37 | 41 | 50 |
Gain on valuation of derivatives | - | - | - | - | - | - | - | - | - | - | - | 27 |
Surrender value of insurance policies | - | - | - | - | - | - | - | - | - | - | 3 | 26 |
Foreign exchange gains | - | 72 | 102 | 145 | - | - | 13 | - | - | - | - | - |
Gain on investments in investment partnerships | - | - | - | - | - | 143 | - | 15 | - | - | - | 15 |
Gain on valuation of derivatives | - | - | - | - | - | - | - | - | - | - | - | 27 |
Other | 3 | 13 | 15 | 23 | 1 | 4 | 6 | 15 | 12 | 13 | 12 | 8 |
Surrender value of insurance policies | - | - | - | - | - | - | - | - | - | - | 3 | 26 |
Non-operating income | 46 | 177 | 128 | 175 | 21 | 208 | 89 | 72 | 71 | 71 | 57 | 136 |
Gain on investments in investment partnerships | - | - | - | - | - | 143 | - | 15 | - | - | - | 15 |
Other | 3 | 13 | 15 | 23 | 1 | 4 | 6 | 15 | 12 | 13 | 12 | 8 |
Non-operating income | 46 | 177 | 128 | 175 | 21 | 208 | 89 | 72 | 71 | 71 | 57 | 136 |
Interest expenses | - | - | - | - | - | - | - | - | - | - | - | - |
Commission for purchase of treasury shares | - | - | - | - | - | - | - | - | - | 2 | 2 | 1 |
Foreign exchange losses | 34 | - | - | - | 46 | - | - | 2 | 1 | 15 | 49 | - |
Loss on valuation of derivatives | - | - | 1 | - | 4 | - | - | - | - | - | 29 | - |
Foreign exchange losses | 34 | - | - | - | 46 | - | - | 2 | 1 | 15 | 49 | - |
Other | 4 | 3 | 1 | - | 5 | 2 | 4 | 5 | 1 | 2 | 1 | 1 |
Other | 4 | 3 | 1 | - | 5 | 2 | 4 | 5 | 1 | 2 | 1 | 1 |
Non-operating expenses | 43 | 3 | 5 | 2 | 51 | 3 | 13 | 7 | 6 | 20 | 83 | 2 |
Non-operating expenses | 43 | 3 | 5 | 2 | 51 | 3 | 13 | 7 | 6 | 20 | 83 | 2 |
Ordinary profit (loss) | 801 | 444 | 285 | 373 | 483 | 397 | 403 | 470 | 817 | 1,099 | 790 | 653 |
Profit (loss) before income taxes | 774 | 451 | 330 | 407 | 456 | 400 | 403 | 388 | 1,008 | 1,099 | 790 | 653 |
Income taxes - current | 327 | 118 | 149 | 159 | 191 | 134 | 142 | 164 | 306 | 346 | 241 | 215 |
Income taxes - deferred | 9 | 19 | -18 | -1 | -11 | 14 | -16 | -22 | 1 | -15 | -3 | -23 |
Income taxes | 336 | 137 | 131 | 158 | 179 | 149 | 125 | 142 | 307 | 330 | 238 | 191 |
Profit (loss) | - | - | - | 249 | 276 | 250 | 278 | 246 | 701 | 768 | 552 | 461 |
Profit (loss) attributable to non-controlling interests | - | - | - | 19 | 22 | 12 | 17 | 8 | 27 | 31 | 35 | 19 |
Profit (loss) attributable to owners of parent | - | - | - | 230 | 254 | 237 | 260 | 237 | 674 | 737 | 517 | 442 |